NCT02382185View on ClinicalTrials.gov

Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures

NACompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 28, 2017

Study Completion Date

September 28, 2017

Conditions

Hip Fractures

Interventions

OTHER

Fluid optimisation

The intervention will consist of optimising stroke volume with 250ml of Hartmanns solution

DRUG

Optimisation of blood pressure

Phenylephrine infusion will be used to target a mean arterial blood pressure to within 30% of baseline (preoperative) value

DEVICE

Application of clearsight monitor

The clear sight monitor will be applied to measure stroke volume.

Trial Locations (2)

YO318HE

York Teaching Hospitals NHS Foundation Trust, York

Unknown

Harrogate Hospital, Harrogate

All Listed Sponsors

lead

York Teaching Hospitals NHS Foundation Trust

OTHER

NCT02382185 - Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures | Biotech Hunter | Biotech Hunter